Kristina Burow, Director at Sienna Biopharmaceuticals, Inc. (SNNA), bought 2,015,800 shares at $2.50 ($5.0M) on 2019-02-22, disclosed to the SEC on 2019-02-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.50 | 150,000 | $375K | 7.4% |
| 2 | $2.50 | 1,865,800 | $4.7M | 92.6% |
| Total | $2.50 avg | 2,015,800 | $5.0M | 100% |
| Filing → |
| SRRK | SELL | 2025-05-30 | $160K | — | Filing → |
| MTSR | BUY | 2025-02-03 | $40.0M | — | Filing → |
| BOLD | BUY | 2024-04-04 | $3.2M | — | Filing → |